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How Little We Know
Whereas in Europe and North America
most of the influenza cases are reported
between December and March, in tropical
and subtropical regions such as in Brazil
[1] or in Hong Kong [2] cases are seen
throughout the year. Epidemic peaks in
the tropical areas mostly occur in between
those found in the Northern and Southern
hemispheres. A recent survey over 7 years
in Brazil showed that annual peaks of
influenza cases occurred in association
with the rainy seasons [3]. Important
reports on spatial and temporal data that
describe the global circulation of influenza
highlight the fact that there is virtually no
data from Africa [4,5]. Indeed, until
recently, the burden of influenza in Africa
was believed to be negligible. However,
sporadic reports from the Gambia [6],
Senegal [7], Congo [8], Madagascar [8],
Kenya [9], Ivory Coast [10], and from
Gabon [11], have indicated that influenza
is circulating and may be causing epidem-
ics regularly. The study in Gabon record-
ed extremely high levels of antibodies to
influenza A H3N2 virus in schoolchildren
[11]. The haemagglutination inhibition
(HI) antibodies to this influenza A virus
at titers of 1,530 (ranging from 80 to
17,920) indicated that the virus had been
circulating within the community in the
recent past. In addition, almost all chil-
dren, had anti-H1N1 HI titers above 40,
while 40% showed antibodies to influenza
B with HI titers of 40 or above, again
highlighting the fact that multiple influen-
za virus strains are present in the region.
The recent swine flu pandemic provides
an interesting example. In the WHO
influenza A (H1N1 swine flu) update of
May 2009, many countries, but none in
Africa, reported virus victims [12]; where-
as two reports appeared in October 2009
that showed data on confirmed swine flu
cases from South Africa [13] and Kenya
[14], indicating that the virus was circu-
lating in Africa, but because of the lack of
a rigorous surveillance system, it was not
reported as readily.
Influenza and Other Febrile
Diseases
Clinically, influenza is not distinguish-
able from most other infectious diseases
with fever in the tropics. In this context
malaria is of particular interest when
considering the African continent. In
tropical Africa, malaria is an important
infectious disease and is still thought to be
the main cause of febrile episodes in
children. However, the threshold of clin-
ical manifestation of malaria is strongly
influenced by the endemicity of Plasmodium
falciparum infection in an area: in very low
transmission areas, any microscopically
detectable parasitemia would indicate
malaria, whereas in regions of high
transmission, a certain parasitemia needs
to be reached to lead to malaria at least
from 5 years of age on. Recent, mainly
unpublished observations show that there
is a considerable drop in malaria incidence
[15] and in P. falciparum prevalence rate
[16] in some African countries. Despite
this reduction, the old habit of treating
every child with fever with antimalarials
continues. As fever due to many infectious
diseases wanes after a few days without
treatment, the belief that medical staff are
successfully treating malaria cases lingers
on.
A recent study in Lambarene, Gabon,
illustrates the extent of the problem and
the unresolved conundrum. In and around
Lambarene all febrile children are still
treated with antimalarials, mainly amodi-
aquine-artesunate [17]. In a study of 1,000
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Summary Points
N Influenza activity displays a seasonal pattern in temperate areas with marked
peaks in the winter, but influenza is present all year round throughout the
tropics.
N A well-established network of surveillance systems, World Health Organization
(WHO) Flu Net, is in place in Europe and North America, providing continuous
data on influenza burden and spread of viral types and subtypes.
N Recent threats of pandemic influenza are prompting the establishment of active
monitoring in parts of Southeast Asia and Latin America.
N But prevalence and incidence of influenza in most tropical countries, especially
in Africa, are largely unknown, and improved surveillance is needed.
N Similarly, little information on influenza vaccine efficacy in tropical Africa is
available, and clinical trials are needed.
PLoS Medicine | www.plosmedicine.org 1 December 2009 | Volume 6 | Issue 12 | e1000182consecutive children presenting with fever
at our research center in Lambarene, the
results from the thick blood smears
indicated that only about 5% had malaria.
Recent serological tests have shown that
parts of the febrile illnesses in Lambarene
are due not only to influenza, but also to
dengue fever, chikungunya disease, and
streptococcal pneumonia [18]. In addi-
tion, in Tanzania where malaria is con-
sidered to be highly endemic, D’Acremont
and coworkers refer to recent data indi-
cating that only 10%–40% of under-5-
year-old patients with fever have malarial
parasites in rural areas [19]. Thus, in
Lambarene and perhaps elsewhere in
Africa, the majority of febrile cases may
be unnecessarily exposed to antimalarial
drugs, with the well-recognized negative
consequences.
It is acknowledged that the problem of
diagnosing influenza-like illness is already
challenging in resource-rich settings ap-
parent from data collected on the ongoing
pandemic of influenza A (H1N1, swine
flu). Examining symptomatic individuals
with recent history of travel to countries
where the H1N1 virus was circulating
indicated that other respiratory viruses
such as rhinovirus, coronavirus, or para-
influenzavirus were responsible for influ-
enza-like illness [20]. Therefore, not
surprisingly, yet often ignored, there is
simultaneous transmission of different
respiratory viruses and bacteria in addition
to malaria that lead to febrile illnesses in
Africa and elsewhere in the tropics.
The task of diagnosing and treating
febrile illnesses properly in resource-poor
tropical settings is daunting. Yet, with
attention to upgrading clinical research in
Africa focused on combatting the well
known diseases such as AIDS, tuberculo-
sis, and malaria, we need to start taking a
few steps towards implementing programs
that deal with influenza-like illness. Thus
in each of the Northern, Western, Eastern,
Central, and Southern African regions one
well-established research center could be
identified to act as a surveillance center.
Already in Senegal and South Africa such
centers exist, but there is a need for
identifying new ones in other regions and
upgrading and intensifying activities in
already existing ones. Training should
ensure that epidemiological data can be
gathered on attack rates, clinical spectrum
of illness, and risk factors, while molecular
diagnosis of collected samples confirms
influenza and identifies the strain/sub-
types. In close collaboration with WHO
centers, the behavior of the influenza virus
would then be monitored properly on the
African continent. Contrary to common
belief, excellent clinical research centers
are developing in Africa with good epide-
miologists, information technology infra-
structure, and laboratory equipment.
Influenza Vaccine
There is no information on influenza
vaccine efficacy in tropical Africa. The
question of whether the immune system of
populations living in tropical African
environments would react similarly to a
vaccine developed mainly for populations
restricted to certain geographical areas of
the world needs to be considered. Hel-
minthic infections, malaria, and other
chronic parasitic infections along with
nutritional status lead to altered function-
ing of the immune system [11]. Not only
Th2 responses [21] but also regulatory T
cells are expanded during many parasitic
infections [21,22] and are thought to affect
responses to unrelated antigens. Interest-
ingly, a study of meningococcal vaccina-
tion of infants in Ghana showed lower
titres of MenA and MenC bactericidal
antibodies than in other studies in Africa
[23].
In a recent trial in Gabon, schoolchil-
dren from a rural and a semi-urban setting
were vaccinated with influenza vaccine
[11]. Clear immunological differences
were seen in response to the vaccine in
rural versus semi-urban children. Weaker
Th1 and pro-inflammatory cytokine re-
sponses to influenza virus antigens were
seen in vaccinated rural children com-
pared to the semi-urban vacinees. Anti-
body levels following vaccination in-
creased in all, but to a different extent in
subjects from rural than in semi-urban
areas. The antibody response following
vaccination to A-H1N1 and B virus strains
were significantly lower in rural compared
to urban schoolchildren. The clinical
relevance of such findings remains unan-
swered, even 30 years after studies of
McGregor in the Gambia examining
influenza-like illness and reporting differ-
ences in antibody reactivity in African
populations and populations of European
descent [24].
Therefore it is important to undertake
clinical trials with this vaccine in different
regions of Africa. The end point in these
studies should be the occurrence of
influenza cases to assess the efficacy of
the vaccine in Africa and learn about a
threshold for a protective HI titer.
Concluding Remarks
Taken together, data from sporadic
studies suggest that influenza is prevalent
in Africa and the disease may have
considerable impact on morbidity and
mortality on the continent. A raised
awareness of the presence of common
febrile diseases such as influenza is essen-
tial for the clinical management of pa-
tients. To this end proper surveillance
systems should be set up in already existing
and well-established clinical research cen-
ters to understand the epidemiology of
influenza in Africa, which in turn may
help the processes of decision making
regarding influenza vaccination on the
continent, which may have a high impact
on health in Africa.
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